David Pernock

2020 - Eagle Pharmaceuticals

In 2020, David Pernock earned a total compensation of $3.8M as President and Chief Operating Officer at Eagle Pharmaceuticals, a 19% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$245,600
Option Awards$1,604,636
Salary$606,530
Stock Awards$1,285,485
Other$44,189
Total$3,786,440

Pernock received $1.6M in option awards, accounting for 42% of the total pay in 2020.

Pernock also received $245.6K in non-equity incentive plan, $606.5K in salary, $1.3M in stock awards and $44.2K in other compensation.

Rankings

In 2020, David Pernock's compensation ranked 3,038th out of 13,090 executives tracked by ExecPay. In other words, Pernock earned more than 76.8% of executives.

ClassificationRankingPercentile
All
3,038
out of 13,090
77th
Division
Manufacturing
1,186
out of 5,621
79th
Major group
Chemicals And Allied Products
451
out of 2,254
80th
Industry group
Drugs
390
out of 1,954
80th
Industry
Pharmaceutical Preparations
291
out of 1,459
80th

Pay ratio

David Pernock's Pay$3,786,440
Median Employee's Pay$254,007
Pay Ratio

15

to 1

In 2020, the annual total compensation of David Pernock was $3,786,440.

The annual total compensation of the median employee at Eagle Pharmaceuticals was $254,007.

The ratio of David Pernock's pay to the pay of median employee was therefore 15 to one.

Source: SEC filing on April 30, 2021.

Pernock's colleagues

We found five more compensation records of executives who worked with David Pernock at Eagle Pharmaceuticals in 2020.

2020

Scott Tarriff

Eagle Pharmaceuticals

Chief Executive Officer

2020

Pete Meyers

Eagle Pharmaceuticals

Chief Financial Officer

2020

Adrian Hepner

Eagle Pharmaceuticals

Chief Medical Officer

2020

Brian Cahill

Eagle Pharmaceuticals

Chief Financial Officer

2020

Judith Ng-Cashin

Eagle Pharmaceuticals

Chief Medical Officer

News

You may also like